Clinical Trial Update: Pharmacokinetics, Safety, and Efficacy of Dolutegravir Dispersible Tablets in Young Children Living With HIV [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pharmacokinetics, safety, and efficacy of dolutegravir dispersible tablets in young children living with HIV.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• dolutegravir dispersible tablets (dolutegravir)

Snippet

Sponsor: Chulalongkorn University | Conditions: Pediatric HIV Infection | Phase 2 | Status: UNKNOWN